GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

L&C Bio Co 290650.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

22,550

-5.05%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2029
Revenue₩169.07bn₩1.03trn
Revenue, highest₩180.22bn₩1.21trn
Revenue, lowest₩160.41bn₩935.96bn
Earnings per share111.38—
Earnings per share, highest219.79—
Earnings per share, lowest56.45—
Analysts32

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026
Forecast136.30
Reported123.85
Difference-9.1%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

6 / 10

Revenue growth 25.2% a year over 10 years. Return on equity -69.7%.

Model fair value

40,360.59

From earnings 40,360.59, from revenue 27,222.03.

Piotroski score

4 / 9

A nine-point test of financial strength, for 31 Dec 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.